Fifteen years have passed since the conception of the Kobe Biomedical Innovation Cluster (KBIC), which has now grown to include nearly 300 companies. KBIC has produced numerous innovations that have attracted attention both locally and internationally, including the world’s first clinical research using iPS (Induced Pluripotent Stem) cells, and is expected to make further progress in the future.
For companies involved in the medical field, the city of Kobe promises a top-notch environment for establishing a business.
KBIC, which has grown to become one of the largest projects of its type in the country,is ideal for making new business networks.I think that business people will also find KBIC’s regular Cluster Exchange Meetings useful as a place for gathering cutting-edge information from researchers and other firms and as a forum for business matching.
Listening to messages from the representatives of companies that have actually invested in the city will give you an appreciation of the business opportunities offered by operating in Kobe.
Despite Kobe’s experience of the Great Hanshin Earthquake, the citizens, companies, and government of our city have combined their strengths to achieve a powerful recovery. In addition to being a symbol of the city’s recovery and development, I believe that the KBIC is a project that will lead Japanese industry in the twenty-first century.
Going forward, Kobe will improve the welfare of its citizens and the level of medical care in other Asian countries and around the world by disseminating state-of-the-art medical technologies that can make global contributions.
I will do my utmost to establish Kobe as a bright, creative city of the future.
Kizo Hisamoto, Mayor of Kobe